| Term 
 | Definition 
 
        | Non-steroidal anti-inflammatory drugs Suppress signs/symptoms of inflammation via inhibition of COX
 Decreased inflammation, pain and fever
 |  | 
        |  | 
        
        | Term 
 
        | Salicylates Mechanism of action?
 |  | Definition 
 
        | COX inhibition (reversible and irreversible) Ab-Ag inhibition at high concentrations
 Barrier formation → interfere with leukocyte migration
 Block signal transduction in inflammatory cells
 |  | 
        |  | 
        
        | Term 
 
        | Salicylates Effect at low dose? Elimination?
 |  | Definition 
 
        | Pain and fever relief First order elimination
 |  | 
        |  | 
        
        | Term 
 
        | Salicylates Effect at high dose? Elimination?
 |  | Definition 
 
        | Anti-inflammatory Zero order elimination; enzymes become saturated
 |  | 
        |  | 
        
        | Term 
 
        | Salicylates Adverse Effects?
 |  | Definition 
 
        | GI intolerance → inhibition of protective effects of prostaglandins Increased formation of leukotrienes
 Ulcer activity
 Renal failure → RBF is regulated by PGs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PG analog NSAIDs may cause ulcers
 PG combats ulcer activity
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indole derivative Efficacious COX inhibitor
 Psychiatric effects, most commonly severe frontal headaches
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | COX inhibitor → analgesic, antipyretic, anti-inflammatory T1/2 of naproxen is 14 hours
 Longer lasting effect
 Problematic for toxicities
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | COX inhibitor → analgesic, antipyretic, anti-inflammatory T1/2 of ibuprofen = 2-6 hours
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Disease-modifying antirheumatic drugs Slow the progress of rheumatoid arthritis
 Block/release cytokine action
 Lose effect (5 year benefit)
 Toxic to skin, blood, liver, kidney and eye
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Structural analogue of folic acid Interferes with purine synthesis and pro-inflammatory cytokines
 Anti-cancer drug
 Teratogenic, causes birth defects
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Remicade Monoclonal antibody to TNF-ɑ (pro-inflammatory cytokine)
 IV infusion
 Increased susceptibility to infection and lymphoma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Recombinant protein that fuses 2 TNF-ɑ receptors with IgG1 Subcutaneous
 Increased susceptibility to infection and lymphoma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Monoclonal antibody, binds to CD20 on B cells If anti-TNF-ɑ is ineffective
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibitor of JAK expressed in immune cells JAK-STAT cytokine signalling inhibited → altered transcription of genes
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | NSAID (anti-inflammatory) for acute gout attacks Gout: sodium urate crystals in joints
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-inflammatory for gout arthritis Depolymerization of microtubules in granulocytes → inhibit migration
 GI toxicity: nausea, vomiting, diarrhea
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Xanthine oxidase inhibitor, non-competitive Most common treatment for long-term gout
 Decrease uric acid formation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Xanthine oxidase inhibitor, non-competitive Most common treatment for long-term gout
 Decrease uric acid formation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Uricosuric drug, organic acids Inhibit renal tubular reabsorption of uric acid
 Occupy anion transporter
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Uricosuric drug, organic acid Inhibit renal tubular reabsorption of uric acid
 Occupy anion transporter
 |  | 
        |  |